These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 17845276

  • 1. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, Schlicht P, Houck P, Brar JS, Gershon S.
    Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
    [Abstract] [Full Text] [Related]

  • 2. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL, Frye MA, Altshuler LL, Suppes T, Hellemann G, Black D, Mintz J, Kupka R, Nolen W, Leverich GS, Denicoff KD, Post RM, Keck PE.
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR, BOLDER II Study Group.
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 5. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
    Chengappa KN, Gershon S, Levine J.
    Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
    [Abstract] [Full Text] [Related]

  • 6. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
    Kushner SF, Khan A, Lane R, Olson WH.
    Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
    [Abstract] [Full Text] [Related]

  • 7. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S.
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L, Meng X, Hochfeld M, Stahl SM.
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 10. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [Abstract] [Full Text] [Related]

  • 11. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842
    [Abstract] [Full Text] [Related]

  • 12. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 01; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 13. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
    Saricicek A, Maloney K, Muralidharan A, Ruf B, Blumberg HP, Sanacora G, Lorberg B, Pittman B, Bhagwagar Z.
    J Clin Psychiatry; 2011 Jun 01; 72(6):744-50. PubMed ID: 21034692
    [Abstract] [Full Text] [Related]

  • 14. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M, OBES-002 Study Group.
    Int J Obes Relat Metab Disord; 2004 Nov 01; 28(11):1399-410. PubMed ID: 15486569
    [Abstract] [Full Text] [Related]

  • 15. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F, Hebrani P, Rezaei Ardani A, Rafee E.
    Arch Iran Med; 2011 Jul 01; 14(4):270-5. PubMed ID: 21726104
    [Abstract] [Full Text] [Related]

  • 16. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 01; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 17. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E, Mullen J, Brecher M, Paulsson B, Jones M.
    Curr Med Res Opin; 2005 Jun 01; 21(6):923-34. PubMed ID: 15969892
    [Abstract] [Full Text] [Related]

  • 18. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 01; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B.
    J Clin Psychiatry; 2011 Oct 01; 72(10):1413-22. PubMed ID: 21672493
    [Abstract] [Full Text] [Related]

  • 20. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
    Roy Chengappa KN, Schwarzman LK, Hulihan JF, Xiang J, Rosenthal NR, Clinical Affairs Product Support Study-168 Investigators.
    J Clin Psychiatry; 2006 Nov 01; 67(11):1698-706. PubMed ID: 17196048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.